Table 4.
Accuracy rates in predicting survival status as a result of evaluations of the SVM Kernel machine learning method with the MRMR, Chi2, ANOVA, and Kruskal–Wallis analysis methods.
| Machine learning method | Analysis method | Feature count | Features | Accuracy |
|---|---|---|---|---|
| SVM kernel | MRMR | 9 | Number of cycles of chemotherapy Neutrophils Chemotherapy response Metastasis location CEA ECOG PS LDH Lymphocytes First-line chemotherapy |
87.9% |
| SVM kernel | Chi2 | 10 | Lymphocytes Tumor location Complaints ECOG PS LDH Number of lines of chemotherapy Number of cycles of chemotherapy Metastasis location Chemotherapy response First-line chemotherapy |
87.9% |
| SVM kernel | ANOVA | 3 | Number of lines of chemotherapy Number of cycles of chemotherapy First-line chemotherapy |
87.9% |
| SVM kernel | Kruskal–Wallis | 8 | Neutrophils Tumor location CEA Complaints Number of lines of chemotherapy LDH Number of cycles of chemotherapy First-line chemotherapy |
87.3% |
ANOVA = analysis of variance, CEA = carcinoembryonic antigen, Chi2 = chi-square, ECOG PS = Eastern Cooperative Oncology Group performance status, LDH = lactate dehydrogenase, MRMR = minimum redundancy–maximum relevance, SVM = support vector machine.